Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events groundbreaking method dealing missing patient reported outcome pro data oncology
Market Research We can collaborate with you to develop and support marketing strategies for your pharmaceutical products and/or devices. Our market research services include: Qualitative research (interviews and focus groups) with patients, physicians, …
… of results stemming from the mixing of two essential data descriptors - effect size and precision - into a single … testing. There is a growing drumbeat to ditch this flawed data analytics method and replace it with more insightful and reliable …
… Sarah Sauchelli Toran Patient-Centered Outcomes Assessment Manchester, United … the cross-cultural adaptation and application of patient-reported outcome measures for use in clinical research. She joins …
… and Drug Administration (FDA), is a national electronic data system created to help monitor the safety of … and medical devices. Having a collective network of data providers and scientific collaborators enables … rapidly. The Sentinel system provides extensive health-data resources for safety surveillance, support for …
… address in the next few years. At a time when real-world data is gaining visibility among non-pharmacoepidemiologists, …
… Shanshan Qin Patient-Centered Outcomes Assessment Headquarters - Research … Dr. Qin works on the psychometric evaluation of clinical outcome assessments (COAs) in support of the regulatory … Qin is an experienced programmer of SAS, R, Mplus, and IRT PRO. She has published and presented widely on topics related …
… (HTAR) is due to be introduced in January 2025 for new oncology medicines, advanced therapies (also known as cell … understand disease burdens, unmet medical needs, and patient preferences. We support clinical trial design by … such as clinical outcomes assessments and patient-reported outcomes measures. Pharma manufacturers in the 2 …
… assessment is due to be introduced in January 2025 for new oncology medicines, advanced therapies (also known as cell … understand disease burdens, unmet medical needs, and patient preferences. We support clinical trial design by … such as clinical outcomes assessments and patient-reported outcomes measures. Pharma manufacturers in the two …
… Database analyses using cross-sectional and longitudinal data sources Decision-analytic models Disease prevalence Drug … of risk management plans Literature reviews Measurement of patient preferences for treatment options Meta-analysis …
… of results stemming from the mixing of two essential data descriptors - effect size and precision - into a single … testing. There is a growing drumbeat to ditch this flawed data analytics method and replace it with more insightful and reliable …